The longevity industry has entered a defining decade.
Advances in artificial intelligence, genomics, precision medicine, regenerative therapies, diagnostics and preventive healthcare are transforming how we think about aging. Investment in longevity companies continues to grow as healthy longevity becomes one of the defining opportunities of the 21st century.
Yet despite remarkable scientific progress, one question remains: How do we bring together the people capable of turning innovation into real-world impact?
For entrepreneur and international event founder Irina Biss, the answer lies not only in scientific discovery, but also in collaboration.
Scientific breakthroughs don't change the world on their own. People do. Innovation moves faster when the right people are sitting at the same table.
Irina Biss
This philosophy inspired The Longevity Code Gala Dinner, an invitation-only international gathering connecting physicians, researchers, biotechnology companies, entrepreneurs, investors, family offices and innovators.
Longevity as an Ecosystem
Longevity is no longer viewed solely through the lens of medicine. Artificial intelligence, biotechnology, diagnostics, nutrition, digital health and psychology all contribute to healthier aging. According to Biss, the future belongs to multidisciplinary collaboration, where experts from different sectors work together rather than in isolation.
Creating Spaces Where Innovation Meets Opportunity
As founder of Leadership Access Group, Biss organizes high-level experiences alongside the World Economic Forum in Davos, the Cannes Film Festival and the Venice Film Festival. Its flagship initiative, The Longevity Code Gala Dinner, is held three times each year and is designed to encourage strategic partnerships, investment opportunities and meaningful dialogue between leaders across science, healthcare and business.
